Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Randomized Control Trial to Assess the Efficacy of Tadalafil in Raynaud's Phenomenon in Scleroderma

This study has been completed.
Sponsor:
Collaborators:
Institute of Postgraduate Medical Education and Research
Postgraduate Institute of Medical Education and Research
Army Research and Referral hospital
Information provided by:
Sanjay Gandhi Postgraduate Institute of Medical Sciences
ClinicalTrials.gov Identifier:
NCT01117298
First received: May 3, 2010
Last updated: May 7, 2010
Last verified: May 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2010
  Primary Completion Date: April 2010 (Final data collection date for primary outcome measure)